EEMT 1 recalled over manufacturing violations
- Recall date
- April 17, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Syntho Pharmaceuticals, Inc. recalls EEMT (esterified estrogens and methyltestosterone) 1.25 mg/2.5 mg, tablets,100-count bottle, Rx only, Manufactured By:…
- Recall number
- D-0378-2019
- FDA classification
- Class II
- Brand / firm
- Syntho Pharmaceuticals, Inc.
- Sold / distributed
- Product was sold to the firm's sole distributor who further distributed the product throughout the United States.
Why it was recalled
CGMP deviations: Lots were recalled due to sub-potency and cGMP violations.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
EEMT (esterified estrogens and methyltestosterone) 1.25 mg/2.5 mg, tablets,100-count bottle, Rx only, Manufactured By: Syntho Pharmaceuticals, Inc., Farmingdale, NY 11735, Distributed By: Creekwood Pharmaceutical, Inc., Birmingham, AL 35242, NDC 15310-010-01
Get recall alerts
Free email alert whenever Syntho Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Syntho Pharmaceuticals, Inc.